EBS FY 2015 Earnings — Emergent BioSolutions Inc. Revenue & Financial Results | Market Cap Arena

EBSEmergent BioSolutions Inc.

$430M

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$489M+21.0% YoY

Gross Profit

$272M55.7% margin

Operating Income

$142M28.9% margin

Net Income

$63M12.8% margin

EPS (Diluted)

$1.41

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

-$353,000

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$384M

Stockholders' Equity

$660M

Cash & Equivalents

$313M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$489M	$404M	+21.0%
Gross Profit	$272M	$198M	+37.8%
Operating Income	$142M	$89M	+58.7%
Net Income	$63M	$37M	+71.1%